SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0000950159-16-000447
Filing Date
2016-02-12
Accepted
2016-02-12 09:51:15
Documents
1

Document Format Files

Seq Description Document Type Size
1 QUAKER BIOVENTURES, L.P. SCHEDULE 13G/A tobira13ga.htm SC 13G/A 91558
  Complete submission text file 0000950159-16-000447.txt   93105
Mailing Address
Business Address 2 GREENVILLE CROSSING 4005 KENNETT PIKE STE 220 GREENVILLE DE 19807
QUAKER BIO VENTURES LP (Filed by) CIK: 0001170144 (see all company filings)

IRS No.: 000000000
Type: SC 13G/A

Mailing Address 701 GATEWAY BLVD SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-741-6625
Tobira Therapeutics, Inc. (Subject) CIK: 0001311596 (see all company filings)

IRS No.: 030422069 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87592 | Film No.: 161415521
SIC: 2834 Pharmaceutical Preparations